ABOUT THIS EPISODE
EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to discuss the company’s financial and operational performance for the third quarter ended June 30, 2026, highlighting revenue growth, rising royalty income, improved margins, and several new commercial agreements that continue to expand adoption of its proprietary REV™ dehydration technology.
During the quarter, EnWave reported revenue of $3.31 million, an increase of $569,000 compared to the same period last year. The growth was primarily driven by the sale of a large-scale REV™ machine that had been fully fabricated and held in inventory, along with stronger royalty contributions from existing commercial partners.
Royalty revenue, excluding exclusivity payments, reached $536,000 during the quarter, representing a 24% increase over the prior-year period. The improvement reflects higher product sales by licensed partners and increased production volumes across EnWave’s growing global network of commercial operators.
The company also reported stronger profitability metrics. Gross margin improved to 25% compared with 19% in the same quarter of 2025. Management attributed the improvement primarily to lower fabrication costs and a reduced number of large-scale machines under contract during the period.
Operating discipline also contributed to improved results. Selling, General and Administrative expenses, including Research and Development costs, declined by $205,000 year-over-year. Lower personnel expenses and reduced third-party commissions more than offset increases in professional development initiatives and industry trade show participation.
As a result, EnWave reported an Adjusted EBITDA loss of just $93,000, representing a significant improvement of $482,000 compared to the prior-year quarter. The stronger performance was driven by the equipment sale, growing royalty revenue, and continued cost management efforts.
Beyond the financial results, EnWave continued to expand its commercial footprint through several strategic agreements. The company signed an Equipment Purchase Agreement with Procescir S.A. de C.V. for a second 120kW REV™ machine, demonstrating growing demand from existing customers. It also entered into Technology Evaluation and License Option Agreements with Swiss Cannabis Selection AG and one of the world’s largest multinational food companies, creating potential pathways for future commercial licensing opportunities.
#proactiveinvestors #enwavecorporation #tsxv #enw #REVTechnology #FoodProcessing #DehydrationTechnology #FoodInnovation #AgTech #FoodManufacturing #LatinAmerica #CleanTech #RoyaltyRevenue #FoodProcessing #IndustrialInnovation #AgTech #GrowthStock
During the quarter, EnWave reported revenue of $3.31 million, an increase of $569,000 compared to the same period last year. The growth was primarily driven by the sale of a large-scale REV™ machine that had been fully fabricated and held in inventory, along with stronger royalty contributions from existing commercial partners.
Royalty revenue, excluding exclusivity payments, reached $536,000 during the quarter, representing a 24% increase over the prior-year period. The improvement reflects higher product sales by licensed partners and increased production volumes across EnWave’s growing global network of commercial operators.
The company also reported stronger profitability metrics. Gross margin improved to 25% compared with 19% in the same quarter of 2025. Management attributed the improvement primarily to lower fabrication costs and a reduced number of large-scale machines under contract during the period.
Operating discipline also contributed to improved results. Selling, General and Administrative expenses, including Research and Development costs, declined by $205,000 year-over-year. Lower personnel expenses and reduced third-party commissions more than offset increases in professional development initiatives and industry trade show participation.
As a result, EnWave reported an Adjusted EBITDA loss of just $93,000, representing a significant improvement of $482,000 compared to the prior-year quarter. The stronger performance was driven by the equipment sale, growing royalty revenue, and continued cost management efforts.
Beyond the financial results, EnWave continued to expand its commercial footprint through several strategic agreements. The company signed an Equipment Purchase Agreement with Procescir S.A. de C.V. for a second 120kW REV™ machine, demonstrating growing demand from existing customers. It also entered into Technology Evaluation and License Option Agreements with Swiss Cannabis Selection AG and one of the world’s largest multinational food companies, creating potential pathways for future commercial licensing opportunities.
#proactiveinvestors #enwavecorporation #tsxv #enw #REVTechnology #FoodProcessing #DehydrationTechnology #FoodInnovation #AgTech #FoodManufacturing #LatinAmerica #CleanTech #RoyaltyRevenue #FoodProcessing #IndustrialInnovation #AgTech #GrowthStock
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of Proactive - Interviews for investors.
OTHER EPISODES IN THIS PODCAST
VettaFi Head of Energy Research Stacey Morris joined Steve Darling from Proactive to discuss how Middle East energy supply disruptions could create long-term opportunities for North American energy producers and midstream infrastructure companies.
Morris explained that the US and Canada could beco…
Pantheon Resources PLC (AIM:PANR, OTCQX:PTHRF) newly appointed CEO Dave Wilkins and former CEO Max Easley joined Steve Darling from Proactive to discuss the leadership transition, as Wilkins takes over at the helm of the company, effective immediately. Easley has taken another senior executive role…
Custom Health CEO Shane Bishop joined Steve Darling from to discuss early results from the company’s ongoing commercial program with BKC Pain Specialists & Regenerative Medicine Clinic in Ohio, highlighting how its integrated medication management model is supporting patients living with chroni…
IP Group PLC (LSE:IPO) CEO Greg Smith joined Steve Darling from Proactive to discuss new data showing that investment in UK university spinouts reached £1.56 billion in the first half of 2026, marking the second-highest half-year total recorded over the past decade.
The figures come from a new rep…
Krait Critical Minerals Corp CEO Oscar Mendoza joined Steve Darling from Proactive to discuss the company's expanding US antimony portfolio, its recent acquisition of an antimony asset in Humboldt County, Nevada, and its strategy of acquiring historically producing critical mineral properties acros…
Disclaimer: The podcast and artwork embedded on this page are from Proactive, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.